Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Promising results from the BCN02-Romi study of MVA.HIVconsv vaccine

March 2, 2017

GS-PI-1 is a promising new generation HIV PI with favorable potency and resistance barrier

March 2, 2017

ViiV Healthcare patents HIV integrase inhibitors

Feb. 27, 2017

ViiV Healthcare UK identifies novel HIV integrase inhibitors

Feb. 24, 2017

UB-421 monotherapy shows promise for HAART substitution

Feb. 23, 2017

Gilead tests novel non-catalytic site integrase inhibitor GS-9822 in vivo

Feb. 22, 2017

Neurocognitive effects of cenicriviroc assessed in phase II study

Feb. 21, 2017

Novel HIV capsid inhibitors created at Gilead

Feb. 21, 2017

High virologic response rates seen with bictegravir regimen in phase II trial

Feb. 17, 2017

Hetero Research Foundation patents antiviral agents

Feb. 16, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...